| Boehringer Ingelheim (Schweiz) GmbH - Viramune, Tabletten |
| 54393 | | 01 | | Viramune | | Tabletten | | J05AG01 | | Nevirapine | | 23.12.1997 | | |
|
| Composition |
| nevirapinum 200 mg, cellulosum microcristallinum, lactosum monohydricum 318 mg, povidonum K 25, carboxymethylamylum natricum A corresp. natrium 714 µg, silica colloidalis anhydrica, magnesii stearas pro compresso. |
| Packungsbestandteile |
| Tablets | | | | | Active Agent | Dose |
|---|
| Nevirapine | 200 mg |
| | BAG: Active Agent | Dose |
|---|
| Nevirapine | 200 mg |
| | | | Inactive agents | Dose |
|---|
| Carboxymethylamylum Natricum A | | | Cellulosum Microcristallinum | | | Lactose Monohydrate | 318 mg | | Magnesii Stearas pro Compresso | | | Povidonum K | 25 | | Silica Colloidalis Anhydrica | |
| |
|
|
